Explore the words cloud of the Cardiacom IMPLANT project. It provides you a very rough idea of what is the project "Cardiacom IMPLANT" about.
The following table provides information about the project.
ATRACTOR KUTATASI, FEJLESZTESI ES SZOLGALTATO KFT
|EC max contribution
|50˙000 € (70%)
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
|from 2014-12-01 to 2015-02-28
Take a look of project's partnership.
|ATRACTOR KUTATASI, FEJLESZTESI ES SZOLGALTATO KFT
In OECD countries the most frequent cause of mortality is cardiovascular diseases. Addressing this problem needs a holistic approach, where ICT-based monitoring is in the focus.
The disruptive innovation programme sets the target of performing complex mobile invasive monitoring of cardiovascular and associated diseases, of forecasting the state of the patients, supporting the therapy treatments and assessing the effectiveness of drugs on mobile information-technology-base.
The devices are miniature holter monitors built into the human body, which with their diagnostic algorithm will regularly or continuously assess and check the physiological condition of the users.
Innovation content: 7/24 monitoring, continous data processing, intelligent automated evaluation systems, lifelong mobile crisis management, optimized drug taking protocol, implants with long life.
Main ecomic benefits: higher health and life safety, higher economic efficiency as a result of the improvement in people health condition, less patient-doctor appointment, reduced cost of cardiovascular treatment, reduced number of operations.
Main target group: patients who have been/will be operated on any cardiovascular disease and people who have high risk factor. The business model is built on the sale of appliances and on the sale of the related subscription-based info-communication service packages. According to the initial financial plan we count with a turnover of 100.000 pieces and an outstanding profit and return by the end of the fifth year after the market launch.
We plan the diffusion of the system in three steps with expanding geographical coverage. Before entering the markets we establish dealerships in the regions and develop a regional distributor and technical support system as well.
As desired achievements of the phase 1 five main parts of the Feasibility Study will be elaborated: Market Analysis Business Plan, Marketing Plan, Legal and Organisational Plan and Technological Plan.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACOM IMPLANT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CARDIACOM IMPLANT" are provided by the European Opendata Portal: CORDIS opendata.
SOFT, the first camera-based colorectal cancer screening test to detect occult blood in faeces immediately and with no lab analysis.Read More
PsstMenu allows customers to place orders directly from home or restaurant tables using only a smartphone.Read More
Telocate ASSIST – Development and marketing of an acoustic solution for localization and navigation of people in buildings using the smartphoneRead More